Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Analyses of the Phase 3 Trial of Pridopidine’s Outcome on Function in Huntington Disease (PROOF-HD) Demonstrates Efficacy in Participants Without Antidopaminergic Medications

              Author:Geva, Michal   Reilmann, Ralf   Feigin, Andrew   Rosser, Anne   Kostyk, Sandra   Chen, Kelly   Mehra, Munish   Cohen, Yael   Goldberg, Paul   Hayden, Michael   

              Session Name:S30: Movement Disorders: Clinical Trials in Movement Disorders  

              Topic:Movement Disorders  

              Program Number:S30.002  

              Author Institution:Prilenia Therapeutics, Herzlyia, Israel  George-Huntington-Institute, Muenster, Germany  NYU Langone Health, New York, NY  University of Cardiff, Cardiff, United Kingdom  Ohio State University College of Medicine, Dublin, OH  Biometrics Department, Tigermed-BDM Inc, Bangalore, India